科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Clinical and translational science2026-09-01

Artificial Intelligence in Model-Informed Drug Development: Augmentation, Acceleration, and Regulatory Preparation.

Hao Zhu, Ruihao Huang, Menglun Wang, Lixia Zhang, Hanrui Zhang, Yutao Gong, Rajnikanth Madabushi, Qi Liu

原始摘要(英文原文)· Original abstract
The convergence of MIDD and AI represents a natural evolution from established quantitative frameworks toward a broader, more powerful computational toolbox that can address persistent MIDD challenges such as high-dimensional data integration, complex biology, and operational constraints in evidence generation. AI can both enhance traditional MIDD through hybrid approaches and extend MIDD's horizon to include various AI models. Recent publications of guidance demonstrate the agency's preparation on the acceptance of AI in MIDD.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Artificial Intelligence in Model-Informed Drug Development: Augmentation, Acceleration, and Regulatory Preparation. — 科研速览 Science Skim